Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Page 1
Managing Dry Eye Disease with Novel Medications: Mechanism, Study Validity, Safety, Efficacy, and Practical Application.
Wong JC, Barak A. Wong JC, et al. Among authors: barak a. Pharmacy (Basel). 2024 Jan 23;12(1):19. doi: 10.3390/pharmacy12010019. Pharmacy (Basel). 2024. PMID: 38392926 Free PMC article. Review.
In conclusion, these FDA-approved novel medications exhibit safety and efficacy in managing DED. Further research is needed on long-term outcomes, efficacy, and side-effect comparisons, and combination therapy benefits....
In conclusion, these FDA-approved novel medications exhibit safety and efficacy in managing DED. Further research is needed on long-term …
Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocarbon liquid using a two-step vitrectomy technique.
Fleissig E, Barak A, Goldstein M, Loewenstein A, Schwartz S. Fleissig E, et al. Among authors: barak a. Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1341-1347. doi: 10.1007/s00417-017-3648-3. Epub 2017 Apr 15. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28412773
All patients underwent a 23G PPV, subretinal tPA injection and a medium term PFCL tamponade. A second stage PPV for PFCL removal was performed 7-17 days later. ...CONCLUSIONS: SMH displacement using subretinal tPA injection and medium term PFCL tamponade is an effec …
All patients underwent a 23G PPV, subretinal tPA injection and a medium term PFCL tamponade. A second stage PPV for PFCL removal was …
SURGICAL MANAGEMENT OF RETINAL DETACHMENT IN OSTEOGENESIS IMPERFECTA: CASE REPORT AND REVIEW OF THE LITERATURE.
Fleissig E, Barak A. Fleissig E, et al. Among authors: barak a. Retin Cases Brief Rep. 2019 Winter;13(1):43-46. doi: 10.1097/ICB.0000000000000527. Retin Cases Brief Rep. 2019. PMID: 28085759 Review.
The patient was promptly treated with scleral buckling. RESULTS: Long-term follow-up has shown a good clinical outcome, with no recurrence of the retinal detachment. ...
The patient was promptly treated with scleral buckling. RESULTS: Long-term follow-up has shown a good clinical outcome, with no recur …
Quantitation of bleeding symptoms in a national registry of patients with inherited platelet disorders.
Revel-Vilk S, Richter C, Ben-Ami T, Yacobovich J, Aviner S, Ben-Barak A, Kuperman AA, Ben-Barak S, Kaplinsky C, Miskin H, Tamary H, Kenet G. Revel-Vilk S, et al. Among authors: ben barak a. Blood Cells Mol Dis. 2017 Sep;67:59-62. doi: 10.1016/j.bcmd.2016.11.013. Epub 2016 Dec 18. Blood Cells Mol Dis. 2017. PMID: 27998672
Abnormal score was associated with a longer time of follow-up, OR 1.19 (95% CI 1.04-1.36). CONCLUSION: Long term follow-up of patients with IPDs is important as bleeding risks may increase with time. ...
Abnormal score was associated with a longer time of follow-up, OR 1.19 (95% CI 1.04-1.36). CONCLUSION: Long term follow-up of patient …
Outcomes of Scleral Buckle Removal: Experience from the Last Decade.
Moisseiev E, Fogel M, Fabian ID, Barak A, Moisseiev J, Alhalel A. Moisseiev E, et al. Among authors: barak a. Curr Eye Res. 2017 May;42(5):766-770. doi: 10.1080/02713683.2016.1245423. Epub 2016 Dec 2. Curr Eye Res. 2017. PMID: 27911111
Redetachment can occur many years following the removal and long-term follow up in these patients is warranted....
Redetachment can occur many years following the removal and long-term follow up in these patients is warranted....
Evaluation of pain during intravitreal Ozurdex injections vs. intravitreal bevacizumab injections.
Moisseiev E, Regenbogen M, Rabinovitch T, Barak A, Loewenstein A, Goldstein M. Moisseiev E, et al. Among authors: barak a. Eye (Lond). 2014 Aug;28(8):980-5. doi: 10.1038/eye.2014.129. Epub 2014 Jun 13. Eye (Lond). 2014. PMID: 24924442 Free PMC article.
This finding may be a potential advantage for Ozurdex, and may serve to improve patient compliance with future long-term treatment protocols....
This finding may be a potential advantage for Ozurdex, and may serve to improve patient compliance with future long-term treatment pr …
Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion.
Moisseiev E, Goldstein M, Waisbourd M, Barak A, Loewenstein A. Moisseiev E, et al. Among authors: barak a. Eye (Lond). 2013 Jan;27(1):65-71. doi: 10.1038/eye.2012.226. Epub 2012 Nov 16. Eye (Lond). 2013. PMID: 23154502 Free PMC article.
PURPOSE: To evaluate the long-term visual prognosis and complications of patients who received intravitreal Ozurdex injections for the treatment of macular edema (ME) due to retinal vein occlusion (RVO). ...Complications included 10 patients with cataract progression, 1 wi …
PURPOSE: To evaluate the long-term visual prognosis and complications of patients who received intravitreal Ozurdex injections for th …
Visual prognosis and complications following silicone oil removal.
Moisseiev E, Ohana O, Gershovitch L, Barak A. Moisseiev E, et al. Among authors: barak a. Eur J Ophthalmol. 2013 Mar-Apr;23(2):236-41. doi: 10.5301/ejo.5000199. Eur J Ophthalmol. 2013. PMID: 23065851
Our results provide a thorough contemporary analysis of the visual prognosis and complication rates after SOR. Avoiding SOR with long-term silicone oil retention may be advisable in hypotonous eyes....
Our results provide a thorough contemporary analysis of the visual prognosis and complication rates after SOR. Avoiding SOR with long-ter …
The effect of intravitreal bevacizumab (Avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization.
Barak A, Burgansky-Eliash Z, Barash H, Nelson DA, Grinvald A, Loewenstein A. Barak A, et al. Eur J Ophthalmol. 2012 May-Jun;22(3):423-30. doi: 10.5301/ejo.5000074. Eur J Ophthalmol. 2012. PMID: 22081670
PURPOSE: To study the short-term effects of intravitreal bevacizumab (Avastin) on retinal blood flow velocity and compare them to clinical outcomes assessed by optical coherence tomography (OCT) and tests of visual acuity. ...RESULTS: A good correlation was found between t …
PURPOSE: To study the short-term effects of intravitreal bevacizumab (Avastin) on retinal blood flow velocity and compare them to cli …
22 results